SS

Stephen T. Schlachter

AB Array Biopharma: 13 patents #53 of 335Top 20%
PT Peloton Therapeutics: 9 patents #7 of 18Top 40%
Genentech: 9 patents #330 of 2,392Top 15%
ET Edgewise Therapeutics: 7 patents #1 of 7Top 15%
IC Icos: 7 patents #28 of 106Top 30%
AM Amgen: 4 patents #785 of 2,867Top 30%
TU The Upjohn: 3 patents #141 of 528Top 30%
LP Luitpold Pharmaceuticals: 2 patents #8 of 27Top 30%
PC Pharmacia & Upjohn Company: 2 patents #209 of 713Top 30%
📍 Boulder, CO: #70 of 5,018 inventorsTop 2%
🗺 Colorado: #473 of 40,980 inventorsTop 2%
Overall (All Time): #59,509 of 4,157,543Top 2%
47
Patents All Time

Issued Patents All Time

Showing 26–47 of 47 patents

Patent #TitleCo-InventorsDate
8404681 Xanthones, thioxanthones and acridinones as DNA-PK inhibitors James Halbrook, Edward A. Kesicki, Laurence E. Burgess, Charles Todd Eary, Justin G. Schiro 2013-03-26
8329709 5H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitors Anna L. Banka, Josef R. Bencsik, James F. Blake, Martin F. Hentemann, Nicholas C. Kallan +5 more 2012-12-11
8242115 Materials and methods to potentiate cancer treatment James Halbrook, Edward A. Kesicki, Laurence E. Burgess, Charles Todd Eary, Justin G. Schiro +3 more 2012-08-14
8138181 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors Shelley Allen, Julie Marie Greschuk, Nicholas C. Kallan, Fredrik P. Marmsater, Mark Munson +5 more 2012-03-20
8063050 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors Ian S. Mitchell, James F. Blake, Rui Xu, Nicholas C. Kallan, Dengming Xiao +9 more 2011-11-22
8003651 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors Ian S. Mitchell, James F. Blake, Rui Xu, Nicholas C. Kallan, Dengming Xiao +8 more 2011-08-23
7179912 Materials and methods to potentiate cancer treatment James Halbrook, Edward A. Kesicki, Laurence E. Burgess, Charles Todd Eary, Justin G. Schiro +3 more 2007-02-20
7176229 Cyclic AMP-specific phosphodiesterase inhibitors Timothy J. Martins, Kerry W. Fowler, Joshua Odingo, Edward A. Kesicki, Amy Oliver +4 more 2007-02-13
6998416 Cyclic AMP-specific phosphodiesterase inhibitors Timothy J. Martins, Kerry W. Fowler, Joshua Odingo, Edward A. Kesicki, Amy Oliver +4 more 2006-02-14
6716871 Cyclic AMP-specific phosphodie sterase inhibitors Timothy J. Martins, Kerry W. Fowler, Joshua Odingo, Edward A. Kesicki, Amy Oliver +4 more 2004-04-06
6680336 Cyclic AMP-specific phosphodiesterase inhibitors Timothy J. Martins, Kerry W. Fowler, Joshua Odingo, Laurence E. Burgess 2004-01-20
6458813 Substituted pyridine compounds and methods of use Nathan B. Mantlo, John A. Josey 2002-10-01
6423710 Cyclic AMP-specific phosphodiesterase inhibitors Timothy J. Martins, Kerry W. Fowler, Joshua Odingo, Edward A. Kesicki, Amy Oliver +4 more 2002-07-23
6376489 Cyclic AMP-specific phosphodiesterase inhibitors Timothy J. Martins, Kerry W. Fowler, Joshua Odingo, Laurence E. Burgess 2002-04-23
6333341 Substituted pyridine compounds and methods of use Nathan B. Mantlo, John A. Josey 2001-12-25
6184237 Substituted pyridine compounds and methods of use Nathan B. Mantlo, John A. Josey 2001-02-06
6043248 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase Richard A. Nugent, Michael J. Murphy, Joel Morris, Richard C. Thomas, Donn Wishka +2 more 2000-03-28
6022884 Substituted pyridine compounds and methods of use Nathan B. Mantlo, John A. Josey 2000-02-08
5981537 Pyrimidine-thioalkyl and alkylether compounds Richard A. Nugent, Michael J. Murphy, Joel Morris, Richard C. Thomas, Donn Wishka +3 more 1999-11-09
5643895 Phosphonoacetic esters and acids as anti-inflammatories Richard A. Nugent, David Anderson 1997-07-01
5565441 Phosphonoacetic esters and acids as anti-inflammatories Richard A. Nugent, David Anderson 1996-10-15
5397774 Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories Richard A. Nugent 1995-03-14